French R - Search Results

1

Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection.

Pires A, Greenshields-Watson A, Jones E, Smart K, Lauder SN, Somerville M, Milutinovic S, Kendrick H, Hindley JP, French R, Smalley MJ, Watkins WJ, Andrews R, Godkin A, Gallimore A. Pires A, et al. Among authors: french r. Cancer Immunol Res. 2020 Dec;8(12):1520-1531. doi: 10.1158/2326-6066.CIR-20-0070. Epub 2020 Oct 6. Cancer Immunol Res. 2020. PMID: 33023965 Free PMC article.

2

Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.

Yeo SK, French R, Spada F, Clarkson R. Yeo SK, et al. Among authors: french r. Breast Cancer Res Treat. 2017 Apr;162(3):465-477. doi: 10.1007/s10549-017-4149-0. Epub 2017 Feb 11. Breast Cancer Res Treat. 2017. PMID: 28190248 Free article.

3

Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.

Wakefield A, Soukupova J, Montagne A, Ranger J, French R, Muller WJ, Clarkson RW. Wakefield A, et al. Among authors: french r. Cancer Res. 2013 Jan 15;73(2):745-55. doi: 10.1158/0008-5472.CAN-12-1321. Epub 2012 Nov 13. Cancer Res. 2013. PMID: 23149915

4

Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.

French R, Hayward O, Jones S, Yang W, Clarkson R. French R, et al. Mol Cancer. 2015 Dec 15;14:209. doi: 10.1186/s12943-015-0478-y. Mol Cancer. 2015. PMID: 26667821 Free PMC article.

5

Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Piggott L, Omidvar N, Martí Pérez S, French R, Eberl M, Clarkson RW. Piggott L, et al. Among authors: french r. Breast Cancer Res. 2011 Sep 14;13(5):R88. doi: 10.1186/bcr2945. Breast Cancer Res. 2011. PMID: 21914219 Free PMC article.

6

The Discovery of a Novel Antimetastatic Bcl3 Inhibitor.

Soukupová J, Bordoni C, Turnham DJ, Yang WW, Seaton G, Gruca A, French R, Lee KY, Varnava A, Piggott L, Clarkson RWE, Westwell AD, Brancale A. Soukupová J, et al. Among authors: french r. Mol Cancer Ther. 2021 May;20(5):775-786. doi: 10.1158/1535-7163.MCT-20-0283. Epub 2021 Mar 1. Mol Cancer Ther. 2021. PMID: 33649105

7

Heterogeneity of Mammary Stem Cells.

French R, Tornillo G. French R, et al. Adv Exp Med Biol. 2019;1169:119-140. doi: 10.1007/978-3-030-24108-7_7. Adv Exp Med Biol. 2019. PMID: 31487022 Review.

8

Epigenetic regulation of cancer stem cell formation and maintenance.

French R, Pauklin S. French R, et al. Int J Cancer. 2021 Jun 15;148(12):2884-2897. doi: 10.1002/ijc.33398. Epub 2020 Nov 30. Int J Cancer. 2021. PMID: 33197277 Free PMC article. Review.

9

Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Piggott L, Omidvar N, Martí Pérez S, French R, Eberl M, Clarkson RW. Piggott L, et al. Among authors: french r. Breast Cancer Res. 2015 Jul 16;17(1):96. doi: 10.1186/s13058-015-0597-9. Breast Cancer Res. 2015. PMID: 26177636 Free PMC article. No abstract available.

10

Targeting TGFβ Signalling in Cancer: Toward Context-Specific Strategies.

French R, Feng Y, Pauklin S. French R, et al. Trends Cancer. 2020 Jul;6(7):538-540. doi: 10.1016/j.trecan.2020.03.010. Epub 2020 Apr 8. Trends Cancer. 2020. PMID: 32278685 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

901 results

Search Page

Filters